Blood parameters differentiate post COVID-19 condition from Myalgic Encephalomyelitis/Chronic Fatigue Syndrome and Fibromyalgia
Karen Giménez-Orenga(Universitat de València), Elisa Oltra(Universitat de València), Justine Pierquin, Alexandre Lucas(Université Toulouse III - Paul Sabatier), Eva Martín‐Martínez(Hospital de Manises), Hervé Perron(Université Claude Bernard Lyon 1), Joanna Brunel, Benjamin Charvet(Université Claude Bernard Lyon 1), Margot Lemarinier(Université Toulouse III - Paul Sabatier), Steven D.E. Fried(Université Toulouse III - Paul Sabatier)
Cited by 5
Related Papers
An ancestral retroviral protein identified as a therapeutic target in type-1 diabetes
|JCI Insight|2017|84
Therapeutic Potential of Human Adipose-Derived Stem Cells (ADSCs) from Cancer Patients: A Pilot Study
|PLoS ONE|2014|61
Induction of Proinflammatory Multiple Sclerosis-Associated Retrovirus Envelope Protein by Human Herpesvirus-6A and CD46 Receptor Engagement
|Frontiers in Immunology|2018|57
Human Endogenous Retrovirus as Therapeutic Targets in Neurologic Disease
|Pharmaceuticals|2021|43
HERV-W ENV antigenemia and correlation of increased anti-SARS-CoV-2 immunoglobulin levels with post-COVID-19 symptoms
|Frontiers in Immunology|2022|41